Related Experiment Video
Updated: Mar 10, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Evaluation of a Voluntary Work Site Weight Loss Program on Hypertension
Conrad P Earnest1, Timothy S Church
1Texas A&M University, Exercise and Sport Nutrition Lab, College Station (Dr Earnest), and ACAP Health, Dallas, Texas (Dr Church).
Objectives:
The aim of this study was to examine the effect of a worksite weight loss program hypertension.
Methods:
Participants [N = 5998; body mass index (BMI) 34 ± 7 m/kg, 33% hypertensive] participating in a 10-week weight loss program were examined for hypertension prevalence within categories of (1) weight gain, or loss (2) less than 3%, (3) 3% to 5%, (4) 5% to 10%, and (5) more than 10% using general linear models or Chi-square analyses.
Results:
We observed a significant dose-response trend for the reduced prevalence of hypertension at follow-up (P-for-trend < 0.001). Baseline versus follow-up comparisons showed those gaining weight (28% vs 25%, adjres. = 2.5) or losing less than 3% (31% vs 25% adjres. = 2.9) were significantly more likely to present with hypertension at follow-up. Those losing 5% to 10% (33% vs 19%, adjres. = -3.2) or more than 10% (39% vs 17%, adjres. = -3.2) were significantly more likely to present without hypertension.
Conclusion:
Weight loss more than 5% significantly reduced workplace hypertension, while gaining weight increased its likelihood.
More Related Videos
03:05Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study
Published on: November 21, 2025
06:13Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health
Published on: December 1, 2023
Related Concept Videos
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension V: Nursing Management
Hypertension and Regulation of Blood Pressure
Hypertension II: Pathophysiology
Hypertension III: Clinical Manifestations and Diagnostic Studies
Atherosclerosis III: Management